{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:08:48Z","timestamp":1785434928735,"version":"3.56.0"},"posted":{"date-parts":[[2025,12,12]]},"group-title":"Neuroscience","reference-count":101,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["MRF2040081"],"award-info":[{"award-number":["MRF2040081"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Paul & Valeria Ainsworth Family"},{"DOI":"10.13039\/501100005662","name":"Neil and Norma Hill Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005662","id-type":"DOI","asserted-by":"crossref"}]},{"award":["R35NS132179"],"award-info":[{"award-number":["R35NS132179"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["P30AG072973"],"award-info":[{"award-number":["P30AG072973"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["RF1AG064227"],"award-info":[{"award-number":["RF1AG064227"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R21TR003589"],"award-info":[{"award-number":["R21TR003589"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["R01AG07816"],"award-info":[{"award-number":["R01AG07816"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"award":["U19AG068054"],"award-info":[{"award-number":["U19AG068054"]}],"id":[{"id":"https:\/\/ror.org\/01cwqze88","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["K23AG090757"],"award-info":[{"award-number":["K23AG090757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"id":[{"id":"https:\/\/ror.org\/02ymzm013","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["23AARG-1023"],"award-info":[{"award-number":["23AARG-1023"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","award":["AARF-23-1145318"],"award-info":[{"award-number":["AARF-23-1145318"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"name":"New Vision Research Charleston Conference on Alzheimer's Disease","award":["2024&#8208;001&#8208;1"],"award-info":[{"award-number":["2024&#8208;001&#8208;1"]}]},{"id":[{"id":"https:\/\/ror.org\/00mv9dj85","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/00xxxe629","id-type":"ROR","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/03wkk5p21","id-type":"ROR","asserted-by":"publisher"}]},{"award":["Wellcome Leap CARE"],"award-info":[{"award-number":["Wellcome Leap CARE"]}],"id":[{"id":"https:\/\/ror.org\/029chgv08","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Answer ALS Foundation"},{"name":"Robert Packard Center for ALS Research at Johns Hopkins University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Large-scale plasma proteomics offers unprecedented opportunities to investigate the systemic biology of neurodegeneration, yet technical heterogeneity, site-specific artifacts, and clinical confounding remain major barriers to reproducible discovery. Leveraging data from 13,733 individuals with Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), frontotemporal dementia (FTD), Parkinson\u2019s disease dementia (PDD), amyotrophic lateral sclerosis (ALS), and non-impaired controls in the Global Neurodegeneration Proteomics Consortium (GNPC), we present a scalable and generalizable analytical framework for harmonizing and interpreting consortium-scale proteomic datasets. Using a high-dimensional perturbation framework, we systematically benchmark five commonly used batch correction methods across a range of realistic confounding structures, including site-disease imbalance, nonlinear effects, and heteroskedasticity. Empirical Bayes modelling via limma consistently emerged as the most robust method, optimally balancing removal of site-related technical variance with retention of disease-relevant biological signal. On this harmonized foundation, we resolve neurodegenerative disease plasma signatures, including a shared immune-metabolic axis in AD and PD, neuromuscular disruption in ALS, and proteostatic imbalance in PD. Tissue and cell-type enrichment highlight widespread immune-endocrine involvement in AD and hematopoietic activation in PD. Demographically matched analyses nominate distinct, candidate biomarkers across diseases, including lipid, redox, and complement factors in AD, lysosomal and cytoskeletal proteins in PD, and muscle-derived markers in ALS. This study establishes a scalable analytical framework for integrating real-world proteomic data and provides a disease-resolved catalogue of circulating signatures to inform biomarker development and targeted intervention across neurodegenerative diseases.<\/jats:p>","DOI":"10.64898\/2025.12.09.693329","type":"posted-content","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T20:10:16Z","timestamp":1765570216000},"source":"Crossref","is-referenced-by-count":1,"title":["Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-8316","authenticated-orcid":false,"given":"Caitlin A.","family":"Finney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3826-7694","authenticated-orcid":false,"given":"Laura M.","family":"Winchester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell H.","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Slawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2001-8470","authenticated-orcid":false,"given":"Jeffrey D.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Global Neurodegeneration Proteomics Consortium (GNPC)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1351-6183","authenticated-orcid":false,"given":"Rowan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Shvetcov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025121513001143000_2025.12.09.693329v1.1","doi-asserted-by":"crossref","unstructured":"Jiang, O. , Liu, J. , Huang, S. , Wang, X.-Y. , Chen, X. , Liu, G.-H. , Yu, K. , Song, W. , Masters, C.L. , Wang, J. , and Wang, Y.-J . (2025). Antiaging strategy for neurodegenerative diseases: From mechanisms to clinical advances. Signal Transduction and Targeted Therapy 10.","DOI":"10.1038\/s41392-025-02145-7"},{"key":"2025121513001143000_2025.12.09.693329v1.2","unstructured":"World Health Organization (2025). Ageing and Health. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health."},{"key":"2025121513001143000_2025.12.09.693329v1.3","first-page":"2937","article-title":"The exapnding burden of neurodegenerative diseases: An unmet medical and social need","volume":"16","year":"2024","journal-title":"Aging and Disease"},{"key":"2025121513001143000_2025.12.09.693329v1.4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","article-title":"Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"GBD 2021 Nervous Systems Disorders Collaborators","year":"2024","journal-title":"The Lancet Neurology"},{"key":"2025121513001143000_2025.12.09.693329v1.5","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0219"},{"key":"2025121513001143000_2025.12.09.693329v1.6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nmeth.3002","article-title":"CPTAC assay portal: A repository of targeted proteomic assays","volume":"11","year":"2014","journal-title":"Nature Methods"},{"key":"2025121513001143000_2025.12.09.693329v1.7","first-page":"389","article-title":"Accelerating Medicines Partnership Alzheimer\u2019s Disease (AMP-AD) Knowledge Portal aids Alzheimer\u2019s drug discovery through open data sharing","volume":"20","year":"2015","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"2025121513001143000_2025.12.09.693329v1.8","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28549"},{"key":"2025121513001143000_2025.12.09.693329v1.9","doi-asserted-by":"crossref","unstructured":"Nelson, B. , Shenton, M.E. , Woods, S.W. , and Accelerating Medicines Partnership Schizophrenia (AMP SCZ) (2025). Pathways to prevention: the Accelerating Medicines Partnership Schizophrenia (AMP SCZ) program. Schizophrenia 11.","DOI":"10.1038\/s41537-025-00605-1"},{"key":"2025121513001143000_2025.12.09.693329v1.10","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/mus.28244","article-title":"Access for ALL in ALS: A large-scale inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis","volume":"70","year":"2024","journal-title":"Muscle & Nerve"},{"key":"2025121513001143000_2025.12.09.693329v1.11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2337\/db25-0042","article-title":"Accelerating Medicines Partnership in Type 2 Diabetes and Common Metabolic Diseases: Collaborating to maximize the value of genetic and genomic data","volume":"74","year":"2025","journal-title":"Diabetes"},{"key":"2025121513001143000_2025.12.09.693329v1.12","first-page":"233","article-title":"Accelerating Medicines Partnership: Organizational structure and preliminary data from the Phase 1 studies of lupus nephritis","volume":"72","year":"2019","journal-title":"Arthritis Care & Research"},{"key":"2025121513001143000_2025.12.09.693329v1.13","unstructured":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (2025). Accelerating Medicines Partnership Autoimmune and Immune-Mediated Diseases (AMP AIM) Program. https:\/\/www.niams.nih.gov\/grants-funding\/niams-supported-research-programs\/accelerating-medicines-partnership-amp."},{"key":"2025121513001143000_2025.12.09.693329v1.14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/d41573-024-00020-8","article-title":"The Bespoke Gene Therapy Consortium: Facilitating development of AAV therapies for rare diseases","volume":"23","year":"2024","journal-title":"Nature Reviews Drug Discovery"},{"key":"2025121513001143000_2025.12.09.693329v1.15","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/d41573-022-00158-3","article-title":"Accelerating therapeutic discoveries for heart failure: A new public-private partnership","volume":"21","year":"2022","journal-title":"Nature Reviews Drug Discovery"},{"key":"2025121513001143000_2025.12.09.693329v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586023-06592-6"},{"key":"2025121513001143000_2025.12.09.693329v1.17","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","article-title":"The Global Neurodegeneration Proteomics Consortium: Biomarker and drug target discovery for common neurodegenerative diseases and aging","volume":"31","year":"2025","journal-title":"Nature Medicine"},{"key":"2025121513001143000_2025.12.09.693329v1.18","doi-asserted-by":"crossref","unstructured":"Gold, L. , Ayers, D. , Bertino, J. , Bock, C. , Bock, A. , Brody, E.N. , Carter, J. , Dalby, A.B. , Eaton, B.E. , Fitzwater, T. , et al. (2010). Aptamer-based multiplexed proteomic technology for biomarker discovery. PLOS One 5.","DOI":"10.1371\/journal.pone.0015004"},{"key":"2025121513001143000_2025.12.09.693329v1.19","doi-asserted-by":"crossref","unstructured":"Rohloff, J. , Gelinas, A.D. , Jarvis, T.C. , Ochsner, U.A. , Schneider, D.J. , Gold, L. , and Janjic, N . (2014). Nucleic acid ligands with protein-like side chains: Modified aptamers and their use as diagnostic and therapeutic agents. Molecular Therapy: Nucleic Acids 3.","DOI":"10.1038\/mtna.2014.49"},{"key":"2025121513001143000_2025.12.09.693329v1.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00216-007-1486-6"},{"key":"2025121513001143000_2025.12.09.693329v1.21","doi-asserted-by":"crossref","unstructured":"Kirsher, D.Y. , Chand, S. , Phong, A. , Nguyen, B. , Szoke, B.G. , and Ahadi, S . (2025). Current landscape of plasma proteomics from technical innovations to biological insights and biomarker discovery. Communications Chemistry 8.","DOI":"10.1038\/s42004-025-01665-1"},{"key":"2025121513001143000_2025.12.09.693329v1.22","doi-asserted-by":"crossref","unstructured":"Raffield, L.M. , Dang, H. , Pratte, K.A. , Jacobson, S. , Gillenwater, L.A. , Ampleford, E. , Barjaktarevic, I. , Basta, P. , Clish, C.B. , Comellas, A.P. , et al. (2020). Comparison of proteomic assessment methods in multiple cohort studies. Proteomics 20.","DOI":"10.1002\/pmic.201900278"},{"key":"2025121513001143000_2025.12.09.693329v1.23","doi-asserted-by":"crossref","unstructured":"Cuklina, J. , Lee, C.H. , Williams, E.G. , Sajic, T. , Collins, B.C. , Martinez, M.R. , Sharma, V.S. , Wendt, F. , Goetze, S. , Keele, G.R. , et al. (2021). Diagnostics and correction of batch effects in large-scale proteomic studies: A tutorial. Molecular Systems Biology 17.","DOI":"10.15252\/msb.202110240"},{"key":"2025121513001143000_2025.12.09.693329v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIBTECH.2017.02.012"},{"key":"2025121513001143000_2025.12.09.693329v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/biostatistics\/kxab039"},{"key":"2025121513001143000_2025.12.09.693329v1.26","doi-asserted-by":"crossref","unstructured":"Yu, Y. , Mai, Y. , Zheng, Y. , and Shi, L . (2024). Assessing and mitigating batch effects in large-scale omics studies. Genome Biology 25.","DOI":"10.1186\/s13059-024-03401-9"},{"key":"2025121513001143000_2025.12.09.693329v1.27","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.csbj.2022.08.022","article-title":"Perspectives for better batch effect correction in mass-spectrometry-based proteomics","volume":"20","year":"2022","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"2025121513001143000_2025.12.09.693329v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2008.04.014"},{"key":"2025121513001143000_2025.12.09.693329v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4756"},{"key":"2025121513001143000_2025.12.09.693329v1.30","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa520"},{"key":"2025121513001143000_2025.12.09.693329v1.31","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2009). ggplot2 (Springer).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"2025121513001143000_2025.12.09.693329v1.32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts034"},{"key":"2025121513001143000_2025.12.09.693329v1.33","doi-asserted-by":"crossref","unstructured":"Ritchie, M.E. , Phipson, B. , Wu, D. , Hu, Y. , Law, C.W. , Shi, W. , and Smyth, G.K . (2015). limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research 43.","DOI":"10.1093\/nar\/gkv007"},{"key":"2025121513001143000_2025.12.09.693329v1.34","first-page":"1","article-title":"MatchIt: Nonparametric preprocessing for parametric causal inference","volume":"42","year":"2011","journal-title":"Journal of Statistical Software"},{"key":"2025121513001143000_2025.12.09.693329v1.35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku443"},{"key":"2025121513001143000_2025.12.09.693329v1.36","doi-asserted-by":"crossref","unstructured":"Xia, J. , Gill, E. , and Hancock, R.E.W . (2015). NetworkAnalyst for statisical, visual and network-based approahes for meta-analysis of expression data. Nature Protocols 10 (823-844).","DOI":"10.1038\/nprot.2015.052"},{"key":"2025121513001143000_2025.12.09.693329v1.37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkz240"},{"key":"2025121513001143000_2025.12.09.693329v1.38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku1003"},{"key":"2025121513001143000_2025.12.09.693329v1.39","first-page":"1551","article-title":"Large-scale gene function analysis with PANTHER classification system","volume":"8","year":"2019","journal-title":"Nature Protocols"},{"key":"2025121513001143000_2025.12.09.693329v1.40","first-page":"27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"38","year":"2000","journal-title":"Nucleic Acids Research"},{"key":"2025121513001143000_2025.12.09.693329v1.41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkj067"},{"key":"2025121513001143000_2025.12.09.693329v1.42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkm958"},{"key":"2025121513001143000_2025.12.09.693329v1.43","first-page":"1074","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","year":"2017","journal-title":"Nucleic Acids Research"},{"key":"2025121513001143000_2025.12.09.693329v1.44","doi-asserted-by":"crossref","unstructured":"Uhlen, M. , Fagerberg, L. , Hallstrom, B.M. , Lindskog, C. , Oksvold, P. , Mardinoglu, A. , Sivertsson, A. , Kampf, C. , Sjostedt, E. , Asplund, A. , et al. (2015). Tissue-based map of the human proteome. Science 347.","DOI":"10.1126\/science.1260419"},{"key":"2025121513001143000_2025.12.09.693329v1.45","doi-asserted-by":"crossref","unstructured":"The Tabula Sapiens Consortium (2022). The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans. Science 376.","DOI":"10.1126\/science.abl4896"},{"key":"2025121513001143000_2025.12.09.693329v1.46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad1025"},{"key":"2025121513001143000_2025.12.09.693329v1.47","doi-asserted-by":"crossref","unstructured":"Hui, H.W.H. , Kong, W. , and Goh, W.W.B . (2024). Thinking points for effective batch correction on biomedical data. Briefings in Bioinformatics 25.","DOI":"10.1093\/bib\/bbae515"},{"key":"2025121513001143000_2025.12.09.693329v1.48","doi-asserted-by":"crossref","unstructured":"Goh, W.W.B. , and Wong, L . (2017). Protein complex-based analysis is resistant to the obfuscating consequences of batch effects - A case study in clinical proteomics. BMC Genomics 18.","DOI":"10.1186\/s12864-017-3490-3"},{"key":"2025121513001143000_2025.12.09.693329v1.49","doi-asserted-by":"crossref","unstructured":"Yu, Y. , Zhang, N. , Mai, Y. , Ren, L. , Chen, Q. , Cao, Z. , Chen, Q. , Liu, Y. , Hou, W. , Yang, J. , et al. (2023). Correcting batch effects in large-scale multiomics studies using a reference-material-based ratio method. Genome Biology 24.","DOI":"10.1186\/s13059-023-03047-z"},{"key":"2025121513001143000_2025.12.09.693329v1.50","doi-asserted-by":"crossref","first-page":"8878","DOI":"10.1002\/alz.14360","article-title":"Large-scale deep proteomic analysis in Alzheimer\u2019s disease brain regions across race and ethnicity","volume":"20","year":"2024","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2025121513001143000_2025.12.09.693329v1.51","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s43587-025-00965-4","article-title":"Plasma proteomic association with Alzheimer\u2019s disease endophenotypes","volume":"5","year":"2025","journal-title":"Nature Aging"},{"key":"2025121513001143000_2025.12.09.693329v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.10.016"},{"key":"2025121513001143000_2025.12.09.693329v1.53","doi-asserted-by":"crossref","unstructured":"Fernandes, H.J.R. , Patikas, N. , Foskolou, S. , Field, S.F. , Park, J.-E. , Byrne, M.L. , Bassett, A.R. , and Metzakopian, E . (2020). Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses. Cell Reports 33.","DOI":"10.1016\/j.celrep.2020.108263"},{"key":"2025121513001143000_2025.12.09.693329v1.54","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70277-5"},{"key":"2025121513001143000_2025.12.09.693329v1.55","doi-asserted-by":"crossref","unstructured":"Mark, J.R. , and Tansey, M.G . (2025). Immune cell metabolic dysfunction in Parkinson\u2019s disease. Molecular Neurodegeneration 20.","DOI":"10.1186\/s13024-025-00827-y"},{"key":"2025121513001143000_2025.12.09.693329v1.56","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae177"},{"key":"2025121513001143000_2025.12.09.693329v1.57","doi-asserted-by":"crossref","unstructured":"Swerdlow, R.H . (2017). Mitochondria and mitochondrial cascades in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease 62.","DOI":"10.3233\/JAD-170585"},{"key":"2025121513001143000_2025.12.09.693329v1.58","first-page":"364","article-title":"Immune system responses in Parkinson\u2019s disease: Early and dynamic","volume":"49","year":"2018","journal-title":"European Journal of Neuroscience"},{"key":"2025121513001143000_2025.12.09.693329v1.59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-190848","article-title":"Is Alzheimer\u2019s disease a liver disease of the brain","volume":"75","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"2025121513001143000_2025.12.09.693329v1.60","first-page":"1232","article-title":"Gut microbiota: From the forgotten organ to a potential key player in the pathology of Alzheimer\u2019s disease","volume":"75","year":"2020","journal-title":"The Journals of Gerontology: Series A"},{"key":"2025121513001143000_2025.12.09.693329v1.61","first-page":"3466","article-title":"Mechanistic insights and emerging therapeutic targets of Alzheimer\u2019s disease: From the perspective of inter-organ cross-talk","volume":"16","year":"2024","journal-title":"Aging and Disease"},{"key":"2025121513001143000_2025.12.09.693329v1.62","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2018.10.029","article-title":"The key role of T cells in Parkinson\u2019s disease pathogenesis and therapy","volume":"60","year":"2019","journal-title":"Parkinsonism & Related Disorders"},{"key":"2025121513001143000_2025.12.09.693329v1.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2004.08.021"},{"key":"2025121513001143000_2025.12.09.693329v1.64","doi-asserted-by":"crossref","unstructured":"Bhatia, D. , Grozdanov, V. , Ruf, W.P. , Kassubek, J. , Ludolph, A.C. , Weishaupt, J.H. , and Danzer, K.M . (2021). T-cell dysregulation is associated with disease severity in Parkinson\u2019s disease. Journal of Neuroinflammation 18.","DOI":"10.1186\/s12974-021-02296-8"},{"key":"2025121513001143000_2025.12.09.693329v1.65","doi-asserted-by":"crossref","unstructured":"Dhanwani, R. , Lima-Junior, J.R. , Sethi, A. , Pham, J. , Williams, G. , Frazier, A. , Xu, Y. , Amara, A.W. , Standaert, D.G. , Goldman, J.G. , et al. (2022). Transcriptional analysis of peripheral memory T cells reveals Parkinson\u2019s disease-specific gene signatures. npj Parkinson\u2019s Disease 8.","DOI":"10.1038\/s41531-022-00282-2"},{"key":"2025121513001143000_2025.12.09.693329v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/35086067"},{"key":"2025121513001143000_2025.12.09.693329v1.67","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1038\/s41591-025-03890-6","article-title":"A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis","volume":"31","year":"2025","journal-title":"Nature Medicine"},{"key":"2025121513001143000_2025.12.09.693329v1.68","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12350"},{"key":"2025121513001143000_2025.12.09.693329v1.69","doi-asserted-by":"crossref","unstructured":"Osaki, T. , Uzel, S.G.M. , and Kamm, R.D . (2018). Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Science Advances 4.","DOI":"10.1126\/sciadv.aat5847"},{"key":"2025121513001143000_2025.12.09.693329v1.70","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad202"},{"key":"2025121513001143000_2025.12.09.693329v1.71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.12.025"},{"key":"2025121513001143000_2025.12.09.693329v1.72","doi-asserted-by":"crossref","unstructured":"Pang, W. , and Hu, F . (2023). C9ORF72 suppresses JAK-STAT mediated inflammation. iScience 26.","DOI":"10.1016\/j.isci.2023.106579"},{"key":"2025121513001143000_2025.12.09.693329v1.73","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease","volume":"9","year":"2010","journal-title":"The Lancet Neurology"},{"key":"2025121513001143000_2025.12.09.693329v1.74","doi-asserted-by":"crossref","unstructured":"Pei, Y. , and Maitta, R.W . (2019). Alpha synuclein in hematopoiesis and immunity. Heliyon 5.","DOI":"10.1016\/j.heliyon.2019.e02590"},{"key":"2025121513001143000_2025.12.09.693329v1.75","doi-asserted-by":"crossref","unstructured":"Woo, K.A. , Kim, H.-J. , Lee, C.Y. , Shin, J.H. , Sun, C. , Im, H. , An, H. , Lim, J. , Choi, S.-Y. , Koh, Y. , and Jeon, B . (2024). Parkinson\u2019s disease is associated with clonal hematopoiesis with TET2 mutation. npj Parkinson\u2019s Disease 10.","DOI":"10.1038\/s41531-024-00784-1"},{"key":"2025121513001143000_2025.12.09.693329v1.76","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2014.07.014"},{"key":"2025121513001143000_2025.12.09.693329v1.77","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3102"},{"key":"2025121513001143000_2025.12.09.693329v1.78","doi-asserted-by":"publisher","DOI":"10.1038\/nrn3880"},{"key":"2025121513001143000_2025.12.09.693329v1.79","doi-asserted-by":"crossref","first-page":"530","DOI":"10.14283\/jpad.2023.28","article-title":"Reproductive markers in Alzheimer\u2019s disease progression: The Framingham Heart Study","volume":"10","year":"2023","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"key":"2025121513001143000_2025.12.09.693329v1.80","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9315-y"},{"key":"2025121513001143000_2025.12.09.693329v1.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2009.04.015"},{"key":"2025121513001143000_2025.12.09.693329v1.82","doi-asserted-by":"crossref","unstructured":"De Luca, C. , Colangelo, A.M. , Alberghina, L. , and Papa, M. (2018). Neuro-immune hemostasis: Homeostasis and diseases in the central nervous system. Frontiers in Cellular Neuroscience 12.","DOI":"10.3389\/fncel.2018.00459"},{"key":"2025121513001143000_2025.12.09.693329v1.83","doi-asserted-by":"crossref","unstructured":"Steinman, J. , Sun, H.-S. , and Feng, Z.-P . (2021). Microvascular alterations in Alzheimer\u2019s disease. Frontiers in Cellular Neuroscience 14.","DOI":"10.3389\/fncel.2020.618986"},{"key":"2025121513001143000_2025.12.09.693329v1.84","doi-asserted-by":"crossref","unstructured":"De Plano, L.M. , Saitta, A. , Oddo, S. , and Caccamo, A. (2024). Epigenetic changes in Alzheimer\u2019s disease: DNA methylation and histone modification. Cells 13.","DOI":"10.3390\/cells13080719"},{"key":"2025121513001143000_2025.12.09.693329v1.85","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1016\/j.cell.2025.06.031","article-title":"Single-cell multiregion epigenomic rewiring in Alzheimer\u2019s disease progression and cognitive resilience","volume":"188","year":"2025","journal-title":"Cell"},{"key":"2025121513001143000_2025.12.09.693329v1.86","doi-asserted-by":"crossref","unstructured":"Bali, B.K. , Park, J.H. , Bergendorf, A.M. , Proctor, E.A. , and Brubaker, D.K . (2025). Translational disease modeling of peripheral blood identifies type 2 diabetes biomarkers predictive of Alzheimer\u2019s disease. npj Systems Biology and Applications 11.","DOI":"10.1038\/s41540-025-00539-5"},{"key":"2025121513001143000_2025.12.09.693329v1.87","first-page":"1","article-title":"Unravelling the potential neuroprotective facets of erythropoietin for the treatment of Alzheimer\u2019s disease","volume":"37","year":"2021","journal-title":"Metabolic Brain Disease"},{"key":"2025121513001143000_2025.12.09.693329v1.88","doi-asserted-by":"crossref","unstructured":"Sosa, S. , Bringas, G. , Urrutia, N. , Penalver, A.I. , Lopez, D. , Gonzalez, E. , Fernandez, A. , Hernandez, Z.M. , Vina, A. , Pena, Y. , et al. (2023). NeuroEPO plus (NeuralCIM) in mild-to-moderate Alzheimer\u2019s clinical syndrome: The ATHENEA randomized clinical trial. Alzheimer\u2019s Research & Therapy 15.","DOI":"10.1186\/s13195-023-01356-w"},{"key":"2025121513001143000_2025.12.09.693329v1.89","doi-asserted-by":"crossref","unstructured":"Chen, J.J. , Thiyagarajah, M. , Song, J. , Chen, C. , Herrmann, N. , Gallagher, D. , Rapoport, M.J. , Black, S.E. , Ramirez, J. , Andreazza, A.C. , et al. (2022). Altered central and blood glutathione in Alzheimer\u2019s disease and mild cognitive impairment: A meta-analysis. Alzheimer\u2019s Research & Therapy 14.","DOI":"10.21203\/rs.3.rs-430047\/v1"},{"key":"2025121513001143000_2025.12.09.693329v1.90","doi-asserted-by":"crossref","unstructured":"Dolle, C. , and Tzoulis, C. (2025). NAD augmentation as a disease-modifying strategy for neurodegeneration. Trends in Endocrinology & Metabolism.","DOI":"10.1016\/j.tem.2025.03.013"},{"key":"2025121513001143000_2025.12.09.693329v1.91","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14585"},{"key":"2025121513001143000_2025.12.09.693329v1.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1999.tb00724.x"},{"key":"2025121513001143000_2025.12.09.693329v1.93","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1998.9652"},{"key":"2025121513001143000_2025.12.09.693329v1.94","doi-asserted-by":"crossref","unstructured":"Martin, L. , Boutwell, B.B. , Messerlian, C. , and Adams, C.D . (2024). Mendelian randomization reveals apolipoprotein B shortens healthspan and possibly increases risk for Alzheimer\u2019s disease. Communications Biology 7.","DOI":"10.1038\/s42003-024-05887-2"},{"key":"2025121513001143000_2025.12.09.693329v1.95","doi-asserted-by":"crossref","unstructured":"Baird, A.L. , Westwood, S. , and Lovestone, S . (2015). Blood-based proteomic biomarkers of Alzheimer\u2019s disease pathology. Frontiers in Neurology 6.","DOI":"10.3389\/fneur.2015.00236"},{"key":"2025121513001143000_2025.12.09.693329v1.96","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41591-025-03835-z","article-title":"APOE \u03b54 carriers share immune-related proteomic changes across neurodegnerative diseases","volume":"31","author":"The Global Neurodegeneration Proteomics Consortium","year":"2025","journal-title":"Nature Medicine"},{"key":"2025121513001143000_2025.12.09.693329v1.97","doi-asserted-by":"crossref","unstructured":"Rauch, J.N. , Chen, J.J. , Sorum, A.W. , Miller, G.M. , Sharf, T. , See, S.K. , Hsieh-Wilson, L.C. , Kampmann, M. , and Kosik, K.S . (2018). Tau internalization is regulated by 6-O sulfatin on heparan sulfate proteoglycans (HSPGs). Scientific Reports 8.","DOI":"10.1038\/s41598-018-24904-z"},{"key":"2025121513001143000_2025.12.09.693329v1.98","unstructured":"Mishal, R. , and Chang, K.-C . (2025). Insights from TPPP3 and its family member proteins in neuronal diseases. Neural Regeneration Research."},{"key":"2025121513001143000_2025.12.09.693329v1.99","doi-asserted-by":"crossref","unstructured":"Olah, J. , Lehotzky, A. , Szunyogh, S. , Szenasi, T. , Berki, T. , and Ovadi, J . (2022). Modulatory role of TPPP3 in microtubule organization and its impact on alpha-synuclein pathology. Cells 11.","DOI":"10.3390\/cells11193025"},{"key":"2025121513001143000_2025.12.09.693329v1.100","doi-asserted-by":"crossref","unstructured":"You, J. , Wang, L. , Wang, Y. , Kang, J. , Yu, J. , Cheng, W. , and Feng, J . (2024). Prediction of future Parkinson disease using plasma proteins combined with clinical-demographic measures. Neurology 103.","DOI":"10.1212\/WNL.0000000000209531"},{"key":"2025121513001143000_2025.12.09.693329v1.101","doi-asserted-by":"crossref","unstructured":"Lau, V.Z. , Awogbindin, I.O. , Frenkel, D. , Whitehead, S.N. , and Tremblay, M.-E . (2025). A hypothesis explaining Alzheimer\u2019s disease, Parkinson\u2019s disease, and dementia with Lewy bodies overlap. Alzheimer\u2019s & Dementia 21.","DOI":"10.1002\/alz.70363"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2025.12.09.693329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T21:00:27Z","timestamp":1765832427000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2025.12.09.693329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":101,"URL":"https:\/\/doi.org\/10.64898\/2025.12.09.693329","relation":{},"subject":[],"published":{"date-parts":[[2025,12,12]]},"subtype":"preprint"}}